Durvalumab and tremelimumab in patients with advanced rare cancer: a multi-centre, non-blinded, open-label phase II basket trial
Durvalumab 和 tremelimumab 治疗晚期罕见癌症患者:一项多中心、非盲、开放标签的 II 期篮式试验
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2024.102991
Gupta, Abha A; Tinker, Anna; Jonker, Derek; Jamal, Rahma; Hirte, Hal; Winquist, Eric W; Chu, Quincy; Kollmannsberger, Christian; Wong, Ralph; Alcindor, Thierry; Nielsen, Torsten O; Tsao, Ming; Cottrell, Tricia R; Provencher, Diane; Hilton, John; Krzyżanowska, Monika K; Elser, Christine; Hotte, Sebastien; Sederias, Joana; Zhang, Siwei; Tu, Wei; Dancey, Janet